mitoxantrone has been researched along with Paraneoplastic Syndromes in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaster, JH | 1 |
| Niell, HB | 1 |
| Dohan, FC | 1 |
| Smith, TW | 1 |
| Awan, F | 1 |
| Hamadani, M | 1 |
| Devine, S | 1 |
| Tarraza, HM | 1 |
| Carroll, R | 1 |
| De Cain, M | 1 |
| Jones, M | 1 |
1 review available for mitoxantrone and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Recurrent ovarian carcinoma: presentation as idiopathic thrombocytopenic purpura and a splenic mass.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cys | 1991 |
2 other studies available for mitoxantrone and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Topics: Adult; Antineoplastic Agents; Carcinoma; Cohort Studies; Colonic Neoplasms; Demyelinating Diseases; | 2003 |
Paraneoplastic Sweet's syndrome and the pathergy phenomenon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Drug Eruptions; | 2007 |